NCT02070627View on ClinicalTrials.gov

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Acute CholecystitisAcute Cholangitis
Interventions
DRUG

Indocyanine Green (ICG)

60-30 minutes prior to cholecystectomy, 2.5 mg of indocyanine green (ICG) will be injected intravenously. An additional 2.5 mg of ICG may be injected intraoperatively if the fluorescence fades prior to imaging.

DEVICE

Near Infrared Fluorescence Cholangiography (NIRF-C)

Near infrared fluorescence cholangiography will be performed intraoperatively in order to image anatomy.

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
collaborator

Stryker Instruments

INDUSTRY

lead

Ohio State University

OTHER

NCT02070627 - Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study | Biotech Hunter | Biotech Hunter